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The calcitonin gene-rehted peptide (CGRP) restores an apparant normal ultrastructure in mdgjmdg muscle cells in vitro, including a normal triadic 
organization which is known to be essential for excitation-contraction (E-C) coupling. However, neither slow L-type Cazc channel activity nor 
E-C coupling, which are absent in mdg/mdg muscle, were reestablished. These observations uggest a potential role of CGRP (and also of CAMP 
as the intracellular messenger) in the morphological development of the muscle fiber. 
2+ Muscle; Calcitonin gene-related peptide; Ex~i~tion~ontraction coupling; Ca channel; Triad Muscular dysgeneais 
1. INTRODUCTION 
mdg/mdg mice suffer from a skeletal muscle disease 
[l-3] characterized by an i~ature ultr~tructur~ 
organization of the muscle [1,4-61, a drastic decrease 
of the level of 1,Cdihydropyridine receptor [6] and of 
the L-type Ca2+ channel activity [7,8] and, as a result, 
a lack of contractile activity [6-81. Co-culture of 
diseased mouse cells with spinal cord cells from normal 
mice was shown to restore several features of the nor- 
mal ultrastructure and excitation-contraction (E-C) 
coupling [9]. The calcitonin gene-related peptide 
(CGRP) coexists with acetylcholine in spinal cord 
motoneurons [lo] and affects both the biosynthesis 
[l I- 131 and the biophysical properties of the nicotinic 
acetylcholine receptor. The purpose of this work is to 
describe the spectacular properties of the action of 
CGRP in dysgenic myotubes. 
diluted in 3% BSA in PBS. The incubation with an IgG-anti-IgM an- 
tibody was followed by the incubation of a FITC-conjugated second 
antibody (Burobio). Photomicrographs were taken with a Zeiss 
photo~cro~o~ equipped for observation with fluorescein and 
phase optics. 
For electron microscopy, cultures were fried for 2 h in 2.5B/o 
glutaraldehyde 0.5% tannic acid in 0.1 M phosphate buffer at pH 7.4 
at 4°C followed by 0.6% glutaraldehyde 0.5% tannic acid in the 
same buffer overnight. Post-fixation was performed in 2% osmotic 
acid in 0.1 M phosphate buffer for 1 h at 4°C. Then the cultures were 
dehydrated in graded alcohol and embedded in Epon resin. Ultra-thin 
sections of about 65 nm were stained with a saturated solution of 
uranyl acetate in 50% acetone followed by staining with 0.2% lead 
citrate for 4 min. The observations were made with a Philips EM 410 
electron microscope (accelerating voltage 80 kV, objective aperture 
20 fim). 
2. MATERIALS AND METHODS 
Primary cultures of skeletal muscles from newborn normal and 
mutant mice were prepared as previously described IS]. In treated 
dishes, CGRP was added at the final concentration of lo-’ M after 
the 6th day in culture. Culture dishes were fixed 1 h in 2% parafor- 
maldehyde in 0.1 M phosphate, pH 7.0 at room temperature, im- 
mersed for I5 min in a PBS solution containing 0.1 M glycine and 
washed in PBS for IS min. The cultures were then incubated over- 
night at 4°C in a mouse IgM anti-a-actinin antibody (Amers~m) 
The membrane currents were recorded with the whole-cell variant 
of the patch-chtmp technique [14]. The pipette solution contained (in 
mM): 140 CsCl, 5 EGTA, 4 MgCl2, 3 ATP; this solution was buf- 
fered at pH 7.3 with IO mM Hepes/CsGH. The external solution 
contained (in mM): 140 TEA, 2.5 CaCle, 1 MgCl2, 5 glucose; this 
solution was buffered at pH 7.4 with 10 mM TEAOH. Tetrodotoxin 
(5 PM) was added to the external solution to prevent any contamina- 
tion with Na* currents. Patch pipettes (2-5 MQ) were connected to 
the head stage of the recording apparatus (RK300, Bio-Logic, Greno- 
ble, France). The mechanical activity was recorded sim~taneously 
with the electrical activity using a 128 x 128 photodiode array matrix 
associated with an image analyzer giving an image rate analysis up to 
200/s. 
3. RESULTS AND DISCUSSION 
Correspondence address: M. Laxdunski, Institut de Pharmacologic 
moleculaire t cellulaire, UPR 411 du CNRS, 660 route des Lucioles, 
Sophia Antipolis 06560 Valbonne, France, or F. Rieger, Groupe de 
Biologie et Pathologie neuromusculaires, U.153 INSERM, 17 rue du 
Fer-&Moulin, 75006 Paris, France 
All results presented in this work have been obtained 
with myotubes grown in vitro [4,5] from mutant 
mdg/mdg mice. Their phenotypically normal litter- 
mates will be referred to as + /mdg? since + / + and 
+ /mdg? mice are indistinguishable. Control + /mdg? 
myotubes spontaneously contract and display a regular 
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Fig. I. Morphological reorganization of the internal structure of CGRP-treated mdg/mdg myotubes. (A-C) Immunodetection of cY-actinin as 
a marker of Z line organization (scale bar = 10 pm). (A) In normal contracting myotubes, the transverse sarcomeric organization was observed 
all along the fibers by cY-actinin labelling. (B) In mdg/mdg myotubes, the Lu-actinin labelling appeared diffusely distributed. (C) After CGRP 
treatment, the cy-actinin labelling in mdghdg myotubes demonstrated areas with distinct sarcomeric organization. The myotube on the left is 
out of focus and it is not representative. (D-F) Electron microscopy; myofibrillar and sarcomeric organization of myotubes corresponding to 
those shown in Fig. A-C, respectively. 
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sarcomeric organization and Z striations. mdg/mdg 
myotubes: (i) never normally contract; (ii) lack a nor- 
mal sarcomeric organization; (iii) display an absence of 
basal lamina [15]; and (iv) have an abnormal triadic 
structure [6,9]. mdg/mdg myotubes in culture were 
chronically exposed to 0.1 pM CGRP for 6-7 days. 
After this period of time, major changes in their 
ultrastructure were observed when compared to un- 
treated mutant myotubes. The distribution pattern of 
cu-actinin, an important component of the Z line [ 161, 
was used as an index of the organization of the 
myofibrillar network. Fig. IA-C shows the distribu- 
tion of cY-actinin (using a polyclonal antibody) in 
12-day-old + /mdg?, mdg/mdg, and CGRP-treated 
mdg/mdg myotubes. rr-Actinin is not absent in 
mdg/mdg myotubes (Fig. 1B) but the well-organized 
striated pattern and the well-defined Z lines observed in 
normal myotubes (Fig. 1A) are absent. In contrast, ex- 
tensive areas of quasi-normal sarcomeric organization 
are observed (Fig. 1C) in CGRP-treated mdg/mdg 
myotubes. These observations were confirmed at the 
ultrastructural level by classical electron microscopy 
(Fig. ID-F). In control myotubes, myofibrillar and 
sarcomeric organization are already widespread 
(Fig. lD), although not systematic, as generally observ- 
ed in late fetal muscle. In mdg/mdg myotubes, little or 
no fibrillar or sarcomeric organization is visible 
(Fig. 1E) although some aberrantly deposited Z 
material is sometimes observed, as already reported 
[17]. In CGRP-treated mdg/mdg myotubes, clear 
reorganization has occurred in extended areas in good 
+/mdg? md&dg CGRP treated 
m4v* 
Fig. 2. Histogram representation of sarcomeric organization in 
normal control myotubes and untreated and CGRP-treated mutant 
myotubes. In untreated mutant myotubes, there was essentially no 
sarcomeric organization. After a few days (6-7) in the presence of 
CGRP, mutant myotubes exhibit an increase of organized area which 
becomes intermediate between that of normal and untreated mutant 
myotubes. Micrograph fields were chosen at random, in each 
experiment, and comparable numbers of fields were analyzed under 
each condition. The computer image analysis was performed on a 
TITN Samba system (Grenoble, France) using a simple software 
based on direct manual determination of organized vs inorganized 
areas displayed on screen. 
agreement with the light microscopy observations and 
is typically illustrated by Fig. 1F. Histograms compar- 
ing the organization of cu-actinin in + /mdg, mdg/mdg, 
and CGRP-treated mdg/mdg myotubes are presented 
in Fig. 2. Most of the CGRP-treated myotubes, i.e. 
more than 80%, have gained a normal sarcomeric 
organization. In addition to its effects on the sar- 
comeric structure, CGRP treatment elicits the ac- 
cumulation of a well-defined basal lamina in mdg/mdg 
myotubes (Fig. 3). 
A major defect of mdg/mdg myotubes, which is pro- 
bably a critical factor for the absence of E-C coupling 
in mutant muscle, is the absence of normal triads [6,9] 
with no spaced densities (junctional ‘feet’) between T- 
tubules and the sarcoplasmic reticulum. Upon CGRP 
exposure, most of the triadic junctions acquire regular- 
ly spaced densities (Fig. 3). Out of a total of 36 triads 
observed in an optimal longitudinal orientation, and in 
4 separate experiments, 25 had normal features with 
regularly spaced densities. In normal myotubes almost 
100% of the triads observed possessed regularly spaced 
densities. The total number of triads per volume unit 
did not seem to be significantly different in normal and 
CGRP-treated mdg/mdg myotubes, suggesting a nor- 
mal overall density of differentiated normal sar- 
coplasmic reticulum-T-tubule (SR-TT) junctions. 
Since CGRP had such a remarkable organizing effect 
on the ultrastructure of mdg/mdg myotubes, one could 
have expected that the physiological defects of the 
diseased muscle, i.e. the lack of L-type Ca2’ channel 
activity associated with a drastic decrease of the level of 
1,4_dihydropyridine receptor and the lack of E-C 
coupling, might have also been restored by the peptide 
treatment. Voltage-clamp results presented in Fig. 4 
show that exposure to CGRP does not restore the slow 
L-type Ca2+ current activity which is observed in nor- 
mal muscle and which is virtually absent in non-treated 
mdg/mdg muscle [7,8]. In previous experiments in 
which mutant myotubes were co-cultured with spinal 
cord cells [9], the restoration of a normal mor- 
phogenesis of the triads in innervated mdg/mdg 
myotubes was accompanied by the appearance of L- 
type Ca2+ currents and the restoration of contraction. 
In CGRP-treated myotubes, triads were normally dif- 
ferentiated but slow L-type Ca2+ currents were still ab- 
sent. In addition, contractile activity was observed in 
none of the mutant myotubes tested after exposure to 
CGRP. Chronic treatment with this peptide was 
therefore clearly without effect on both L-type Ca2+ 
channel activity and contraction. Nevertheless, 
modifications of the electrophysiological properties of 
mdg/mdg myotubes were observed after CGRP treat- 
ment. CGRP treatment led to a spontaneous bursting 
activity which was not observed in untreated mdg/mdg 
myotubes (Fig. 5A,B). This spontaneous firing was 
systematically of a higher frequency than that of 
+ /mdg? myotubes in sister cultures (Fig. 5B,C). 
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Pig. 3. Ultrastructural analysis of triadic junctions in the normal, mutant and CGRP-treated mutant myotubes. (A) In normal contracting 
myotubes, triads frequently present well-defined regularly spaced densities (X 130 150, see scale bar in B). (B) In mdg/mdg myotubes, triads are 
rare and spaced densities are not observed between T-tubule and sarcoplasmic reticulum membr~es, ~though unorganized material is frequently 
present (x 130 150, scale bar = 0.1 pm). Q After several days in the presence of CGRP, triads in mdg/mdg myotubes acquire a normal 
morphology with regularly spaced densities (x 130 150, scale bar as in B). (D) Organized basal lamina is not observed in mdg/mdg myotubes 
( x 42 750, scale bar = 0.5 pm). (B) A well-defined basal lamina is present on the surface of CGRP-treated mutant myotubes (x 42 750, scale 
bar as in D). 
The second messenger of CGRP action in muscle has 
previously been shown to be cAh4P [18]. Similarly to 
CGRP, chronic treatment of ~~g/~dg myotubes with 
dibutyryl CAMP (final concentration of 1 /IM) induced 
the differentiation of 87% of the observed triads, as 
well as a sarcomeric organization and a basal lamina 
accumulation (not shown). Spout~eous electrical ac- 
tivity was also observed in mdg/mdg myotubes treated 
with dibutyryl CAMP (Fig. SD). Treatment with 
cholera toxin (2 ng/ml), which is a well-known ac- 
tivator of CAMP production, also mimicked the effects 
described above for CGRP although to a lesser extent 
{not shown). 
The triad is thought o be a key structural element for 
E-C coupling in skeletal muscle. During muscle on- 
togenesis, E-C coupling does not occur as long as triads 
are not formed [19]. Also, removal of the triad struc- 
ture by detub~ation of myotubes by glycerol trea~ent 
eliminates E-C coupling. The voltage-sensitive L-type 
Ca2+ channel, although it is situated in T-tubules, does 
not seem to be the essential element for contraction 
[ 19-221. Elimination of the L-type Ca2” channel activi- 
150 
Volume 263, number 1 FEBS LETTERS April 1990 
Fig. 4. Voltage-clamp analysis of Ca” currents and the associated 
contractions in normal (A), mdg/mdg (B), and CGRP-treated 
mdg/mdg (C) myotubes. Left traces: superimposed CaZf currents 
associated with step depolarizations to -50, -30, -10, +lO, +30, 
+50 mV from a holding potential of -90 mV. Right traces: the 
associated contractions in arbitrary units. In normal myotubes (A), 
the presence of two distinct Ca” currents, a fast activating and 
inactivating current (arrow) with a low membrane potential threshold 
(-50 mV) (Ia& and a slow activating current with a higher threshold 
(-20 mV) (1&. Note the absence of &low and of the contractions 
but the presence of Irat in mdg/mdg (B) and CGRP-treated 
mdg/mdg (C) myotubes. Horizontal bars = 500 ms (A) or 200 ms (B, 
C). Vertical bar = 1 nA. 
ty by Ca2+ removal, blockade with some Ca” channel 
blockers or simply the culture conditions [21,22], hoes 
not eliminate E-C coupling, Situations in which L-type 
Ca2+ channels are functional but triads are not formed, 
do not lead to contraction [22]. The present work 
shows that triad formation induced by CGRP in 
~~g/~~g myotubes is not sufficient by itself to obtain 
muscle contractile activity. 
The cz1 subunit of the 1,6dihydropyridine (DHP) 
receptor seems to serve both as an L-type Ca2+ channel 
and as a voltage sensor t19,21]. In its voltage sensing 
function, the DHP receptor transmits the depolariza- 
tion of the T-tubule membrane (by a mechanism which 
is still unknown but which does not involve transmem- 
brane Ca2+ translocation for the externa_l_medium) to 
ryanodine-sensitive Ca2+ channels located in SR 
‘+ thereby releasing Ca from internal stores for contrac- 
tion 123-251. The DHP receptor is clearly an essential 
element of E-C coupling which probably remains ab- 
sent, in insufficient amounts, or is not functional in 
CGRP-treated mutant myotubes. This suggests that 
normal levels of voltage sensor are not necessary for the 
morphogenesis of muscle ultrastructure and, par- 
ticularly, for triad formation. 
Tanabe et al. [26] have recently published data in- 
D 
Fig. 5. Spontaneous and evoked action potential by anodal break 
stimulation (upper traces) and contractions (lower traces) in arbitrary 
units in normal myotubes (A), mdg/mdg myotubes (B), and 
mdgt’mdg myotubes treated chronically with CGRP (0.1 /rM) (C). 
(A) In normal myotubes, spontaneous action potentials (left traces) 
or evoked action potentials (right traces) induced contractions and 
were followed by a long-lasting aft~-h~~ol~~tion (ahp). (B) 
mdg/mdg myotubes were often quiescent (left trace). Evoked action 
potentials were not followed by an ahp and did not produce 
contractions (right trace). (C) Spontaneous or evoked pattern of 
burst activity in mdg/mdg myotubes treated by CGRP. No 
contractile activity was associated with the action potentials. (D) 
Spontaneous bursting electrical activity (upper trace) without 
mechanical activity (lower trace) induced by chronic application of 
dibutyryl CAMP. Horizontal bar in A = 500 ms; vertical bar in A = 
20 mV. Methods: The external Earle medium contained (in mM): 140 
NaCl, 2 CaCl2, 1 MgCl2, 5 glucose. This solution was buffered at pH 
7.4 with 10 mM Hepes/KOH. Intracellular recordings were made 
using conventional microelectrodes filled with 3 M KCI, with 
resistances of 20-50 MI?. The microelectrode was connected to an 
electrometer amplifier ~WPI.M707) allowing simul~~us current 
injection and voltage recording through the same electrode. 
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dicating that the genome of dysgenic mice lacks a func- 
tional copy of the normal gene for the DHP receptor. 
A mutation of the DHP receptor gene would explain 
that CGRP does not restore L-type Ca2+ channel activi- 
ty and E-C coupling. 
The mdg/mdg muscle has been an important system 
for demonstrating that the ai subunit of the DHP 
receptor is the essential functional subunit for L-type 
Ca2+ channel activity [26,27]. The present work shows 
in addition that this diseased muscle system is of par- 
ticular interest for studying the role of muscle mor- 
phogenesis and the conditions for maturation of the 
structures involved in E-C coupling. It is tempting to 
speculate that CGRP may be one of the trophic factors 
necessary for the maturation, stabilization a d/or 
maintenance of normal cell/cell interactions in the 
neuromuscular system, although no direct evidence has 
yet been gathered for such a role. 
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